Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46591 | 17408630 | Gastroenterology | The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. | 2007 | Details |
| A46592 | 17407723 | Zhonghua Gan Zang Bing Za Zhi | [Changes of liver fibrosis markers in nonalcoholic fatty liver disease patients]. | 2007 | Details |
| A46602 | 17355088 | Semin Diagn Pathol | Alcoholic liver disease. | 2007 | Details |
| A46612 | 17296533 | Clin Gastroenterol Hepatol | Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. | 2007 | Details |
| A46617 | 17268250 | Curr Opin Gastroenterol | Fatty liver and the metabolic syndrome. | 2007 | Details |
| A46623 | 17219068 | Dig Dis Sci | The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. | 2007 | Details |
| A46627 | 17160239 | Arq Gastroenterol | Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis. | 2007 | Details |
| A46633 | 28381952 | Gastroenterol Hepatol (N Y) | The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process. | 2006 | Details |
| A46642 | 16952281 | Am J Gastroenterol | The evolving role of leptin and adiponectin in chronic liver diseases. | 2006 | Details |
| A46666 | 16762000 | Liver Int | Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. | 2006 | Details |
| A46669 | 16729327 | Hepatology | Impact of obesity on treatment of chronic hepatitis C. | 2006 | Details |
| A46680 | 16584696 | Gastroenterol Hepatol | [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. | 2006 | Details |
| A46684 | 16550033 | Curr Opin Gastroenterol | Hepatobiliary pathology. | 2006 | Details |
| A46690 | 16510031 | Curr Gastroenterol Rep | New treatments for nonalcoholic fatty liver disease. | 2006 | Details |
| A46694 | 16471264 | J Soc Biol | [Experimental modulation of apoptosis: physiopathological and therapeutic targets]. | 2005 | Details |
| A46704 | 16369215 | Rev Gastroenterol Disord | Role of liver biopsy in the management of chronic liver disease: selective rather than routine. | 2005 | Details |
| A46715 | 16265231 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease. | 2005 | Details |
| A46720 | 16234011 | Clin Gastroenterol Hepatol | Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease. | 2005 | Details |
| A46726 | 16175602 | Hepatology | Steatohepatitis induced by intragastric overfeeding in mice. | 2005 | Details |
| A46731 | 16137470 | Gastroenterol Hepatol | [Nonalcoholic steatohepatitis associated with ovarian stromal hyperplasia]. | 2005 | Details |
| A46736 | 16083334 | Expert Opin Emerg Drugs | Nonalcoholic fatty liver disease: a review. | 2005 | Details |
| A46741 | 15990637 | J Pediatr Gastroenterol Nutr | Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. | 2005 | Details |
| A46742 | 15990591 | Curr Opin Lipidol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2005 | Details |
| A46746 | 15977205 | Hepatology | Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery. | 2005 | Details |
| A46755 | 15882516 | Med Clin (Barc) | [Pathogenesis of primary nonalcoholic fatty liver disease]. | 2005 | Details |
| A46763 | 15763233 | Clin Liver Dis | Long-term management of alcoholic liver disease. | 2005 | Details |
| A46765 | 15730035 | Ned Tijdschr Geneeskd | [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis]. | 2005 | Details |
| A46766 | 15728360 | Proc Natl Acad Sci U S A | Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. | 2005 | Details |
| A46775 | 15682682 | J Investig Med | Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. | 2004 | Details |
| A46776 | 15670659 | Alcohol | Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. | 2004 | Details |
| A46784 | 15605304 | Semin Liver Dis | Liver pathology in obesity. | 2004 | Details |
| A46786 | 15578508 | Gastroenterology | Serum markers detect the presence of liver fibrosis: a cohort study. | 2004 | Details |
| A46792 | 15508109 | Gastroenterology | Obesity and hepatocellular carcinoma. | 2004 | Details |
| A46795 | 15382171 | Hepatology | Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. | 2004 | Details |
| A46810 | 15086699 | Intern Med J | Nonalcoholic fatty liver disease: is all the fat bad? | 2004 | Details |
| A46816 | 14752843 | Hepatology | Vascular involvement of the liver in Turner's syndrome. | 2004 | Details |
| A46818 | 14720455 | Curr Gastroenterol Rep | New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. | 2004 | Details |
| A46821 | 14687145 | Am J Gastroenterol | Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. | 2004 | Details |
| A46827 | 14507639 | Am J Pathol | Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. | 2003 | Details |
| A46833 | 12957298 | Alcohol | Iron as a co-morbid factor in nonhemochromatotic liver disease. | 2003 | Details |
| A46834 | 12920429 | Gastroenterol Nurs | Nonalcoholic Fatty liver disease. | 2003 | Details |
| A46837 | 12881873 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [Liver fibrosis indexes in nonalcoholic fatty liver disease]. | 2003 | Details |
| A46839 | 12828075 | Hepatogastroenterology | Serum ubiquitin levels in patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A46856 | 12527713 | Mod Pathol | Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. | 2003 | Details |
| A46859 | 12417056 | J Cell Mol Med | Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. | 2003 | Details |
| A46860 | 12408779 | Curr Treat Options Gastroenterol | Therapeutic Options in Nonalcoholic Fatty Liver Disease. | 2002 | Details |
| A46863 | 12235896 | Rev Med Chil | [Obesity: risk factor for steatohepatitis and hepatic fibrosis]. | 2002 | Details |
| A46880 | 11825540 | Curr Gastroenterol Rep | Use of ursodeoxycholic acid in patients with liver disease. | 2002 | Details |
| A46882 | 11755315 | Free Radic Biol Med | Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. | 2002 | Details |
| A46899 | 10811531 | Cell Biol Toxicol | Hepatotoxicity due to mitochondrial dysfunction. | 1999 | Details |
| A46905 | 34970275 | Front Immunol | Macrophage Polarization and Its Role in Liver Disease. | 2021 | Details |
| A46908 | 34817678 | Eur J Nutr | Betaine in ameliorating alcohol-induced hepatic steatosis. | 2021 | Details |
| A46910 | 34646717 | Alcohol Res | Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease. | 2021 | Details |
| A46911 | 34558087 | Alcohol Clin Exp Res | A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease. | 2021 | Details |
| A46913 | 34523155 | Alcohol Clin Exp Res | A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice. | 2021 | Details |
| A46915 | 34428307 | Aliment Pharmacol Ther | Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation. | 2021 | Details |
| A46921 | 34229840 | Clin Liver Dis | Diagnosis of Alcohol-Associated Hepatitis: When Is Liver Biopsy Required? | 2021 | Details |
| A46925 | 34068838 | Nutrients | Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease. | 2021 | Details |
| A46926 | 34066517 | Cells | Chronic Alcohol Exposure of Cells Using Controlled Alcohol-Releasing Capillaries. | 2021 | Details |
| A46930 | 33860120 | Hepatol Commun | Clinical Presentation and Gene Expression of Acute Alcohol-Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis. | 2021 | Details |
| A46933 | 33713857 | Biochem Biophys Res Commun | Mesencephalic astrocyte-derived neurotrophic factor alleviates alcohol induced hepatic steatosis via activating Stat3-mediated autophagy. | 2021 | Details |
| A46936 | 33598648 | JHEP Rep | Gut dysbiosis as a driver in alcohol-induced liver injury. | 2020 | Details |
| A46940 | 33443222 | Proc Natl Acad Sci U S A | Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. | 2020 | Details |
| A46945 | 33162823 | Int J Biol Sci | Emerging Roles of SIRT1 in Alcoholic Liver Disease. | 2020 | Details |
| A46946 | 33132639 | World J Gastroenterol | Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. | 2020 | Details |
| A46949 | 32960884 | PLoS Comput Biol | Alcoholic liver disease: A registry view on comorbidities and disease prediction. | 2020 | Details |
| A46952 | 32790342 | ACS Nano | Luminescence Imaging of Acute Liver Injury by Biodegradable and Biocompatible Nanoprobes. | 2020 | Details |
| A46966 | 32087348 | J Hepatol | Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. | 2020 | Details |
| A46978 | 31491888 | Biomedicines | Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance. | 2019 | Details |
| A46983 | 31321478 | J Mol Med (Berl) | S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver. | 2019 | Details |
| A46988 | 31173814 | J Hepatol | Natural history of histologically proven alcohol-related liver disease: A systematic review. | 2019 | Details |
| A46999 | 30773529 | Med Sci Monit | Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes. | 2019 | Details |
| A47003 | 30658728 | J Hepatol | Non-invasive diagnosis and biomarkers in alcohol-related liver disease. | 2019 | Details |
| A47006 | 30256818 | PLoS One | Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease. | 2018 | Details |
| A47007 | 30248395 | Alcohol | Pharmacokinetic changes of tramadol in rats with hepatotoxicity induced by ethanol and acetaminophen in perfused rat liver model. | 2018 | Details |
| A47009 | 30179264 | Hepatology | Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice. | 2019 | Details |
| A47011 | 30115921 | Nat Rev Dis Primers | Alcoholic liver disease. | 2018 | Details |
| A47013 | 30071471 | Redox Biol | Pomegranate prevents binge alcohol-induced gut leakiness and hepatic inflammation by suppressing oxidative and nitrative stress. | 2018 | Details |
| A47014 | 30048873 | Drug Alcohol Depend | Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. | 2018 | Details |
| A47016 | 29852391 | Biomed Pharmacother | Increased hepatic FAT/CD36, PTP1B and decreased HNF4A expression contributes to dyslipidemia associated with ethanol-induced liver dysfunction: Rescue effect of ginger extract. | 2018 | Details |
| A47035 | 28689299 | J Mol Med (Berl) | 4-O'-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice. | 2017 | Details |
| A47041 | 28467182 | Exp Biol Med (Maywood) | Roles of silent information regulator 1-serine/arginine-rich splicing factor 10-lipin 1 axis in the pathogenesis of alcohol fatty liver disease. | 2017 | Details |
| A47043 | 28274894 | J Ethnopharmacol | Effects of antrosterol from Antrodia camphorata submerged whole broth on lipid homeostasis, antioxidation, alcohol clearance, and anti-inflammation in livers of chronic-alcohol fed mice. | 2017 | Details |
| A47045 | 28134813 | Biomolecules | Key Events Participating in the Pathogenesis of  Alcoholic Liver Disease. | 2017 | Details |
| A47046 | 28112200 | Sci Rep | Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease. | 2017 | Details |
| A47049 | 27871879 | J Hepatol | Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression. | 2016 | Details |
| A47052 | 27824131 | Sci Rep | Infliximab and Dexamethasone Attenuate the Ductular Reaction in Mice. | 2016 | Details |
| A47058 | 27630043 | Nat Commun | MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. | 2016 | Details |
| A47061 | 27404390 | Sci Rep | Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis. | 2016 | Details |
| A47069 | 26934429 | Cochrane Database Syst Rev | Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease. | 2016 | Details |
| A47081 | 26576483 | J Hepatol | Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. | 2015 | Details |
| A47084 | 26511776 | Alcohol Alcohol | The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease. | 2015 | Details |
| A47086 | 26494961 | World J Gastroenterol | Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. | 2015 | Details |
| A47088 | 26459052 | Int Immunopharmacol | Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress. | 2015 | Details |
| A47093 | 26099526 | Gastroenterology | Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. | 2015 | Details |
| A47097 | 26025474 | Biochimie | Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice. | 2015 | Details |
| A47100 | 25923904 | Zebrafish | Development of an Animal Model for Alcoholic Liver Disease in Zebrafish. | 2015 | Details |
| A47108 | 25872593 | Alcohol Clin Exp Res | Alcoholic liver disease: the gut microbiome and liver cross talk. | 2015 | Details |
| A47109 | 25869468 | J Hepatobiliary Pancreat Sci | Recent advancement of molecular mechanisms of liver fibrosis. | 2015 | Details |
| A47114 | 25717264 | World J Gastroenterol | Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation. | 2015 | Details |